Common Blood Pressure Drug Class Tied to 33% Higher Kidney Risk in Type 2 Diabetes, Study Finds

Common Blood Pressure Drug Class Tied to 33% Higher Kidney Risk in Type 2 Diabetics, Study Finds
newstarget.com

Common Blood Pressure Drug Class Tied to 33% Higher Kidney Risk in Type 2 Diabetics, Study Finds

Researchers examining health records of 31,031 adults with Type 2 diabetes found that use of dihydropyridine calcium-channel blockers (DCCBs) was associated with a 33% higher risk of major adverse kidney events, according to findings presented Aug. 1